)
)
Chembio Diagnostics Investor Relations Material
Latest events
Q3 2022
Chembio Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Chembio Diagnostics Inc
Access all reports
Chembio Diagnostics Inc. is a biotechnology company specializing in the development, manufacturing, and commercialization of point-of-care diagnostic products. The company focuses on delivering diagnostic solutions for infectious diseases and other medical conditions. Its offerings utilize proprietary technologies to provide rapid, accurate results in healthcare settings, aiming to support clinical decision-making and public health efforts. Its portfolio encompasses diagnostic assays, devices, and related components tailored to specific testing requirements. Chembio Diagnostics Inc. is headquartered in Hauppauge, New York, and its shares are listed on the NASDAQ.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
CEMI
Country
🇺🇸 United States